Hepatitis C Flashcards
Who does USPSTF recommend screening for HepC?
pts born bt 1945-1965
What is the MC HepC genotype
genotype 1
What factors determine treatment eligibility in HepC?
HCV genotype cirrhosis (absent, compensated, decompensated) prior tx liver transplant other health conditions
What is the duration for most HepC treatment regimens?
6-24weeks
NS3/4A protease inhibitors: MOI
prevent polyprotein processing
inhibits HCV replication directly binding to the NS3/4A protease that cleaves HCV encoded polyproteins
NS5B inhibitors: MOI
inhibit RNA dependent RNA polymerase activity
NS5A inhibitors: MOI
prevent viral assembly and formation of RNA replication complex
NS3/4A protease inhibitors: agents, targeted genotypes
“previr”
Simeprevir (1, 4) Paritaprevir (1, 4) Asunaprevir (1, 4) Grazoprevir (1, 4-6) Glecaprevir (1-6) Voxilaprevir (1-6)
NS5B inhibitors: agents, targeted genotypes
“buvir”
sofosbuvir (1-6)
dasabuvir (1, 4)
beclabuvir (1)
NS5A inhibitors: agents, targeted genotypes
“asvir”
Daclatasvir (1-6) Ledipasvir (1, 4-6) Ombitasvir (1,4) Elbasvir (1-6) Velpatasvir (1-6) Pibrentasvir (1-6)
Genotype 1 Specific Medications
Daklinza (daclatasvir) with Sovaldi (sofosbuvir) +/- ribavirin.
Harvoni (ledipasvir/sofosbuvir) +/- ribavirin
Olysio (simprevir) plus Sovaldi (sofosbuvir) +/- ribavirin
Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir) + ribavirin
Viekira XR (ombitasvir, paritaprevir, ritonavir, dasabuvir) + ribavirin
Zepatier (elbasvir/grazoprevir) +/- ribavirin
Genotype 2 Specific Medications
Sovaldi (sofosbuvir) + ribavirin
Genotype 3 Specific Medications
Daklinza (daclatasvir) with Sovaldi (sofosbuvir) +/- ribavirin.
Sovaldi (sofosbuvir) + ribavirin
Genotype 4 Specific Medications
Harvoni (ledipasvir/sofosbuvir) +/- ribavirin
Sovaldi (sofosbuvir) + ribavirin
Technivie (ombitasvir/paritaprevir/ritonavir) + ribavarin
Zepatier (elbasvir/grazoprevir) +/- ribavirin
Vosevi: agents, ADE
(pan-genotypic)
sofosbuvir/velpatasvir/voxilapresvir
HA
tiredness
diarrhea
nausea